WuXi Biologics (Cayman) I...

PNK: WXIBF · Real-Time Price · USD
3.00
0.00 (0.00%)
At close: Apr 29, 2025, 3:47 PM

Company Description

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally.

The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities.

WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc.

The company was incorporated in 2014 and is headquartered in Wuxi, China.

WuXi Biologics (Cayman) Inc.
WuXi Biologics (Cayman) Inc. logo
Country CN
IPO Date Jan 30, 2018
Industry Biotechnology
Sector Healthcare
Employees 12,575
CEO Dr. Zhisheng Chen Ph.D.

Contact Details

Address:
No. 108, Meiliang Road
Wuxi,
CN
Website https://www.wuxibiologics.com

Stock Details

Ticker Symbol WXIBF
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number KYG970081173
Employer ID -
SIC Code n/a

Key Executives

Name Position
Dr. Weichang Zhou Ph.D. Honorary President of Global Biologics Development, Senior Advisor to Chief Executive Officer & Non-Executive Director
Dr. Zhisheng Chen Ph.D. Chief Executive Officer & Executive Director
Dr. Sherry Gu Ph.D. Chief Technology Officer and Executive Vice President of Global Biologics Development Department
Lihua Yu M.B.A. Chief Operating Officer & Senior Vice President
Ming Tu Chief Financial Officer & Executive Vice President
Dr. Ge Li Ph.D. Founder & Chairman
Dr. Jijie Gu Ph.D. Chief Scientific Officer & President of Global Biologics Research
He Wang Chief Compliance Officer, Senior Vice President and Head of Global Compliance & Risk Management
Li Xiong Vice President & Head of Global Human Resources
Lina Fan Ph.D. Senior Vice President & Head of Investor Relations

Latest SEC Filings

No SEC filings available.